Amended Statement of Ownership (sc 13g/a)
February 14 2020 - 4:05PM
Edgar (US Regulatory)
Securities
and Exchange Commission
Washington,
DC 20549
SCHEDULE 13G/A
Under
the Securities Exchange Act of 1934
(Amendment
No. 1)*
Relmada Therapeutics, Inc.
(Name of Issuer)
Common Stock, par value $0.001 per
share
(Title of Class of Securities)
75955J402
(CUSIP Number)
December 31, 2019
(Date of Event Which Requires Filing of
This Statement)
Check the appropriate box to designate
the rule pursuant to which this Schedule is filed:
*The remainder of this cover page shall
be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for
any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.
The information required in the remainder
of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of
1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions
of the Act (however, see the Notes).
CUSIP No. 75955J402
|
13G
|
Page 2 of 7 Pages
|
1
|
NameS
of Reporting Persons
I.R.S. Identification NOS. of Above Persons (ENTITIES ONLY)
TANG
CAPITAL PARTNERS, LP
|
2
|
Check the Appropriate Box if a Member of a Group*
|
(a)
☐
(b)
☒
|
3
|
SEC Use Only
|
4
|
Citizenship
or Place of Organization
DELAWARE
|
Number of
Shares
BENEFICIALLY
Owned by
Each Reporting
Person with
|
5
|
Sole
Voting Power
0
|
6
|
Shared
Voting Power
1,300,000
|
7
|
Sole
Dispositive Power
0
|
8
|
Shared
Dispositive Power
1,300,000
|
9
|
Aggregate
Amount Beneficially Owned by each Reporting Person
1,300,000
|
10
|
Check
Box if the Aggregate Amount in Row (9) excludes certain shares
¨
|
11
|
Percent
of Class represented by amount in row 9
8.9%
|
12
|
type
of reporting person
pN
|
CUSIP No. 75955J402
|
13G
|
Page
3 of 7 Pages
|
1
|
NameS
of Reporting Persons
I.R.S. Identification NOS. of Above Persons (ENTITIES ONLY)
Tang
Capital Management, LLC
|
2
|
Check the Appropriate Box if a Member of a Group*
|
(a)
☐
(b)
☒
|
3
|
SEC Use Only
|
4
|
Citizenship
or Place of Organization
DELAWARE
|
Number of
Shares
BENEFICIALLY
Owned by
Each Reporting
Person with
|
5
|
Sole
Voting Power
0
|
6
|
Shared
Voting Power
1,300,000
|
7
|
Sole
Dispositive Power
0
|
8
|
Shared
Dispositive Power
1,300,000
|
9
|
Aggregate
Amount Beneficially Owned by each Reporting Person
1,300,000
|
10
|
Check
Box if the Aggregate Amount in Row (9) excludes certain shares
¨
|
11
|
Percent
of Class represented by amount in row 9
8.9%
|
12
|
type
of reporting person
OO
|
CUSIP No. 75955J402
|
13G
|
Page
4 of 7 Pages
|
1
|
NameS
of Reporting Persons
I.R.S. Identification NOS. of Above Persons (ENTITIES ONLY)
Kevin
Tang
|
2
|
Check the Appropriate Box if a Member of a Group*
|
(a) ☐
(b)
☒
|
3
|
SEC Use Only
|
4
|
Citizenship
or Place of Organization
united
states
|
Number of
Shares
BENEFICIALLY
Owned by
Each Reporting
Person with
|
5
|
Sole
Voting Power
0
|
6
|
Shared
Voting Power
1,300,000
|
7
|
Sole
Dispositive Power
0
|
8
|
Shared
Dispositive Power
1,300,000
|
9
|
Aggregate
Amount Beneficially Owned by each Reporting Person
1,300,000
|
10
|
Check
Box if the Aggregate Amount in Row (9) excludes certain shares
¨
|
11
|
Percent
of Class represented by amount in row 9
8.9%
|
12
|
type
of reporting person
IN
|
|
Item 1(a).
|
Name of Issuer:
|
Relmada Therapeutics, Inc.,
a Nevada corporation (the “Issuer”)
|
Item 1(b).
|
Address of Issuer’s Principal Executive Offices:
|
880 Third Avenue, 12th
Floor, New York, NY 10022
|
Item 2(a).
|
Name of Person Filing:
|
This Statement on
Schedule 13G (this “Statement”) is filed by Tang Capital Partners, LP (“Tang Capital Partners”); Tang Capital
Management, LLC, the general partner of Tang Capital Partners (“Tang Capital Management”); and Kevin Tang, the manager
of Tang Capital Management.
|
Item 2(b).
|
Address of Principal Business Office or, if none, Residence:
|
4747 Executive Drive, Suite
510, San Diego, CA 92121
Tang Capital Partners
is a Delaware limited partnership. Tang Capital Management is a Delaware limited liability company. Mr. Tang is a United States
citizen.
|
Item 2(d).
|
Title of Class of Securities:
|
Common Stock, par value
$0.001 per share (the “Common Stock”)
|
Item 2(e).
|
CUSIP Number: 75955J402
|
|
(a)
|
Amount Beneficially Owned:
|
Tang Capital Partners. Tang Capital Partners
is the beneficial owner of 1,300,000 shares of the Issuer’s Common Stock.
Tang Capital Partners shares voting
and dispositive power over such shares with Tang Capital Management and Kevin Tang.
Tang Capital Management. Tang
Capital Management, as the general partner of Tang Capital Partners, may be deemed to beneficially own the shares of the Issuer’s
Common Stock beneficially owned by Tang Capital Partners.
Kevin Tang. Kevin Tang, as
manager of Tang Capital Management, may be deemed to beneficially own the shares of the Issuer’s Common Stock beneficially
owned by Tang Capital Partners.
The percentages used herein are based on 14,673,501
shares of Common Stock outstanding reported to be issued and outstanding as of January 30, 2020 in the Company’s Proxy Statement
on Form DEF 14A filed with the Securities and Exchange Commission on January 31, 2020.
Tang Capital Partners
|
8.9%
|
Tang Capital Management
|
8.9%
|
Kevin Tang
|
8.9%
|
|
(c)
|
Number of shares as to which such person has:
|
(i) sole
power to vote or to direct the vote:
Tang Capital Partners
|
0 shares
|
Tang Capital Management
|
0 shares
|
Kevin Tang
|
0 shares
|
(ii) shared
power to vote or to direct the vote:
Tang Capital Partners
|
1,300,000
shares
|
Tang Capital Management
|
1,300,000 shares
|
Kevin Tang
|
1,300,000 shares
|
(iii) sole
power to dispose or to direct the disposition of:
Tang Capital Partners
|
0 shares
|
Tang Capital Management
|
0 shares
|
Kevin Tang
|
0 shares
|
(iv) shared
power to dispose or to direct the disposition of:
Tang Capital Partners
|
1,300,000
shares
|
Tang Capital Management
|
1,300,000 shares
|
Kevin Tang
|
1,300,000 shares
|
|
Item 5.
|
Ownership of Five Percent or Less of a Class.
|
If
this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial
owner of more than five percent of the class of securities, check the following: ¨
|
Item 6.
|
Ownership of More than Five Percent on Behalf of Another Person.
|
Not applicable
|
Item 7.
|
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported
on by the Parent Holding Company.
|
Not applicable.
|
Item 8.
|
Identification and Classification of Members of the Group.
|
Not applicable.
|
Item 9.
|
Notice of Dissolution of Group.
|
Not applicable.
By signing below I certify that,
to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of
or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held
in connection with or as a participant in any transaction having that purpose or effect.
Signature
After reasonable inquiry and to the best of
my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
Date:
|
February
14, 2020
|
|
|
|
|
|
|
|
TANG CAPITAL PARTNERS, LP
|
|
|
|
|
By:
|
Tang Capital Management, LLC, its General Partner
|
|
|
|
|
|
|
|
By:
|
/s/ Kevin Tang
|
|
|
Kevin Tang, Manager
|
|
|
|
|
|
|
|
TANG CAPITAL MANAGEMENT, LLC
|
|
|
|
|
|
|
By:
|
/s/ Kevin Tang
|
|
|
Kevin Tang, Manager
|
|
|
|
|
|
|
|
/s/ Kevin Tang
|
|
Kevin Tang
|
|
Page 7 of 7 Pages
Relmada Therapeutics (NASDAQ:RLMD)
Historical Stock Chart
From Aug 2024 to Sep 2024
Relmada Therapeutics (NASDAQ:RLMD)
Historical Stock Chart
From Sep 2023 to Sep 2024